Quality Insights Volume 6: Focusing on Returning to Work, Forestry Matters and Privacy Management

The recent spate of incidents related to data compromise across global organizations has increased voter/consumer appetite for tighter protective measures. This article takes you through the nuts and bolts of an effective privacy management system to secure data assets.

In 2020, over five million acres of land across the West Coast of the United States burned in wildfires. While these are not unusual in this region, the severity was unexpected, leading to questions about forestry management practices. California experienced five of its ten largest fires in history in 2020. Across the whole region, 40 people lost their lives and over USD 20 billion in direct costs were accrued. The impact of the fires even caused hazy skies on the other coast. In a region that expects wildfires, 2020 was an exceptional year.

The regulatory surge soon to be heralded by ESG considerations might be too much of a bitter pill to swallow for most organizations. This article provides some context to the increasing ESG regulations and the efforts of SGS in facilitating a seamless transition into this new reality.

One of the biggest challenges for businesses in recent years has been how to successfully navigate the COVID-19 pandemic and its aftermath. While we are not yet clear of the disease, vaccines are now making a return to the office a possibility. For employers and employees, the most pressing question is how can that return to work happen safely?

An upsurge in demand has greeted the recent discovery of the COVID19 vaccine in the saddle, and as expected, the rollout of the vaccine has been met with challenges. In this article, we render valuable insight into efforts aimed at maintaining the supply chain of these vaccines and the role of SGS in flattening the curve of supply chain strains.

The time lags due to FDA resources constraints oft-associated with companies receiving a Substantially Equivalence Determination (510(k) review) to bring their products to the market has proved to be a concern. This article takes stock of the 3P510k process, and SGS involvement in the 3P510K process, with a focus on SGS’s end-to-end assessment capabilities to provide answers with maximum efficiency.

Staying compliant with ISO 13485:2016 ahead of new EU IVD Regulations scheduled for implementation in 2022 is the first step in achieving regulatory compliance for IVD medical device manufacturers. This article beams focus on the journey to ISO 13485 certification journey and SGS’s capabilities in actualizing this first step in the compliance journey of IVD medical device manufacturers.